<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211121053129N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-01</date_registration>
      <primary_sponsor>University of social welfare and rehabilitation sciences</primary_sponsor>
      <public_title>The effect of Tele-rehabilitation on stress urinary incontinence</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Tele-rehabilitation for supervised pelvic floor motor learning exercise with biofeedback in subjects with stress urinary incontinence (SUI)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60122</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Block randomization. The main idea of block randomization is that patients are divided into m blocks. Each block is randomly chosen in order to put n patients in A group and n patients in B group. This method ensures equal treatment allocation within each block if a complete block is used. We select 10 blocks consisting of 4 patients. An equal number of people are assigned to each group in each block. The block randomization method is designed to randomize the distribution of individuals to the study groups so that the sample size of the groups is equal. This method is used to ensure balance in sample size between groups over time. We will identify 10 blocks with 4 patients in each block, two patients in group A (intervention) and two patients in group B (control), and then randomization will be applied to both blocks in the intervention group and the control group. For example, when a participant enters a study, she is asked to select a block from 1 to 10 and then A or B. When one person selects a block, the order of the other three items is randomly defined.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Stress urinary incontinence.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants are remotely supervised and operate the biofeedback device themselves. The treatment program will be done in 4 weeks and 14 sessions. 4 sessions will be held in the first and second week and 3 sessions in the third and fourth week each. The protocol consists of: endurance training, strength training, motor-control and motor-learning training. The duration of holding the slow contraction in endurance training will be 6 to 8 seconds and will be done for 3 sets of 10 repetitions. Immediately after the endurance contraction, rest is given for the duration of the contraction. Strength contraction will include 4 rapid contractions. Rapid contraction lasts for 2 seconds at maximum voluntary contraction followed by 2 seconds of rest. In each session, each contraction will be repeated and practiced in the supine, sitting, and standing positions, and after the patient has been able to perform the contractions correctly, these contractions will be coordinated with the movements of the upper and lower limbs. Intervention 2: Control group: The physiotherapist is present next to the patient. The treatment program will be done in 4 weeks and 14 sessions. 4 sessions will be held in the first and second week and 3 sessions in the third and fourth week each. The protocol consists of: endurance training, strength training, motor-control and motor-learning training. The duration of holding the slow contraction in endurance training will be 6 to 8 seconds and will be done for 3 sets of 10 repetitions. Immediately after the endurance contraction, rest is given for the duration of the contraction. Strength contraction will include 4 rapid contractions. Rapid contraction lasts for 2 seconds at maximum voluntary contraction followed by 2 seconds of rest. In each session, each contraction will be repeated and practiced in the supine, sitting, and standing positions, and after the patient has been able to perform the contractions correctly, these contractions will be coordinated with the movements of the upper and lower limbs.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the individual data of the study participants, such as information about the main outcome or the like, can be shared

When:
Access period starts 6 months after the results are published

To whom:
The data will be available to researchers working in academic and scientific institutions and also People who are in the industry can apply for them.

Conditions:
If necessary, the results and data can be provided without mentioning the name.

Where to obtain:
Contact  the researchers to receive the required documents or data. Contact information:
E-mail:
zah.tajbakhsh@uswr.ac.ir
tshzahra@yahoo.com
Phone number:
09022073102
address: University of social welfare and rehabilitation sciences, Kudakyar Ave., Daneshju Blvd.,Evin

How to obtain:
Request from the researchers and obtain permission from the university

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Tajbakhsh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 43, Shahid jalili Ave., Hengam street, Resalat Square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1677744715</zip>
        <telephone>+98 21 7749 6433</telephone>
        <email>zah.tajbakhsh@uswr.ac.ir</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Tajbakhsh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 43, Shahid jalili Ave., Hengam street, Resalat Square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1677744715</zip>
        <telephone>+98 21 7749 6433</telephone>
        <email>zah.tajbakhsh@uswr.ac.ir</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women aged between 20 to 50 years
Able to use lap-top or computer
Diagnosed with stress urinary incontinence only</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Pregnancy
Delivery within the past six months
Immobility
Grades 3 or 4 pelvic organ prolapse
Diagnosed with any neurologic condition
Having received other treatments for stress urinary incontinence</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N39.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stress incontinence (female) (male)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants are remotely supervised and operate the biofeedback device themselves. The treatment program will be done in 4 weeks and 14 sessions. 4 sessions will be held in the first and second week and 3 sessions in the third and fourth week each. The protocol consists of: endurance training, strength training, motor-control and motor-learning training. The duration of holding the slow contraction in endurance training will be 6 to 8 seconds and will be done for 3 sets of 10 repetitions. Immediately after the endurance contraction, rest is given for the duration of the contraction. Strength contraction will include 4 rapid contractions. Rapid contraction lasts for 2 seconds at maximum voluntary contraction followed by 2 seconds of rest. In each session, each contraction will be repeated and practiced in the supine, sitting, and standing positions, and after the patient has been able to perform the contractions correctly, these contractions will be coordinated with the movements of the upper and lower limbs.</i_keyword>
      <i_keyword>Control group: The physiotherapist is present next to the patient. The treatment program will be done in 4 weeks and 14 sessions. 4 sessions will be held in the first and second week and 3 sessions in the third and fourth week each. The protocol consists of: endurance training, strength training, motor-control and motor-learning training. The duration of holding the slow contraction in endurance training will be 6 to 8 seconds and will be done for 3 sets of 10 repetitions. Immediately after the endurance contraction, rest is given for the duration of the contraction. Strength contraction will include 4 rapid contractions. Rapid contraction lasts for 2 seconds at maximum voluntary contraction followed by 2 seconds of rest. In each session, each contraction will be repeated and practiced in the supine, sitting, and standing positions, and after the patient has been able to perform the contractions correctly, these contractions will be coordinated with the movements of the upper and lower limbs.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>International consultation on incontinence questionnaire-short form score. Timepoint: International consultation on incontinence questionnaire-short form score will be field at baseline (before the intervention) and again at the end of the intervention. Method of measurement: International consultation on incontinence questionnaire-short form.</prim_outcome>
      <prim_outcome>Number of urine leakage. Timepoint: Number of urine leakage will be recorded at baseline (before the intervention) and again at the end of the intervention. Method of measurement: Number of urine leakage will be recorded according to the patients' answer to first question in International consultation on incontinence questionnaire-short form.</prim_outcome>
      <prim_outcome>Incontinence-quality of life questionnaire score. Timepoint: Incontinence-quality of life questionnaire score will be field at baseline (before the intervention) and again at the end of the intervention. Method of measurement: Incontinence-quality of life questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pelvic floor muscle strength. Timepoint: Pelvic floor muscle strength will be evaluated once before the intervention and again at the end of the intervention. Method of measurement: Perineometer.</sec_outcome>
      <sec_outcome>Pelvic floor muscle endurance. Timepoint: Pelvic floor muscle endurance will be evaluated once before the intervention and again at the end of the intervention. Method of measurement: Perineometer.</sec_outcome>
      <sec_outcome>Pelvic floor muscle neuromuscular coordination. Timepoint: Pelvic floor muscle neuromuscular coordination will be evaluated once before the intervention and again at the end of the intervention. Method of measurement: Perineometer.</sec_outcome>
      <sec_outcome>Patient satisfaction score according to The MedRisk instrument for measuring patient satisfaction with physical therapy care score. Timepoint: The MedRisk instrument for measuring patient satisfaction with physical therapy care score will be field after the intervention. Method of measurement: The MedRisk instrument for measuring patient satisfaction with physical therapy care.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of social welfare and rehabilitation sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-20</approval_date>
        <contact_name>Ethics committee of university of social welfare and rehabilitation sciences</contact_name>
        <contact_address>University of social welfare and rehabilitation sciences, Kudakyar Ave., Daneshju Blvd. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
